MedCity News

Providers

Cybersecurity Experts to Hospital Leaders: Think Beyond Traditional Disaster-Recovery Planning

By Jenna Congdon

Providers, Policy

FTC Sends Warning Letters to 24 Healthcare Organizations Over Price Transparency

The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency.

By Marissa Plescia

BioPharma, Startups

Forbion Bucks VC Fundraising Trends, Reeling In €2.3B for Two New Funds

Forbion’s new capital will support two funds that will invest in about 30 companies combined. The new funds for Netherlands-based Forbion come amid a decline in VC fundraising and investments in Europe, according to Pitchbook.

By Frank Vinluan

MedCity Influencers

Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency

Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.

By Lexi Yoo

Latest Video

Latest News

Events

At INVEST Digital Health, Health Wildcatters Will Highlight Latest Cohort of Startups

Health Wildcatters, a Dallas accelerator and INVEST Digital Health partner, has announced the healthcare startups in its latest cohort. Join us at INVEST DIgital Health on October 29 and meet them in person!

By Stephanie Baum

Artificial Intelligence, Health Tech, Providers

A digitally generated image featuring an old-style computer monitor displaying the letters “AI” with neon business crowd. The scene blends retro computing with modern business aesthetics, symbolizing the journey of artificial intelligence from its early beginnings to its growing role in today’s corporate world. Ideal for illustrating themes of digital evolution, business transformation, AI adoption, and technology-driven innovation.

Imprivata CEO: AI Agents Need the Same Scrutiny as an Unvetted Contract Nurse

Imprivata CEO Fran Rosch said AI agents should be treated similarly to the way hospitals treat a new contract nurse — vetted, monitored and then cut off as soon as the job is done.

By Katie Adams

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

What Health Equity Champions Can Learn from Pharmaceutical Sales

The same mechanics can now help people meet new Medicaid work requirements or exemptions, increase referrals to evidence-based health interventions, and dramatically increase enrollment in vital programs that improve health outcomes and reduce inequities.

By Rishi Manchanda

Health Tech

Virtual CKD Solutions Don’t Slow Disease Progression or Reduce Costs, Report Finds

A PHTI analysis found that virtual CKD management programs have little impact on disease progression or healthcare spending and recommends shifting the focus toward earlier diagnosis and treatment.

By Marissa Plescia

Artificial Intelligence, Health Tech, Providers

How Lifepoint Health Is Using AI to Give Nurses Their Time Back

Michelle Watson, Lifepoint Health's chief nurse executive, believes ambient listening and AI-powered patient prioritization are helping nurses reclaim time on tasks that don't require clinical judgment. The goal is to free nurses up for the work that actually requires their expertise.

By Katie Adams

MedCity Influencers

Ethics Isn’t a Pharma Value — It’s a Competitive Moat

Patient trust, physician credibility, and payer goodwill are not soft considerations alongside the balance sheet; they are the mechanism by which a pharmaceutical product generates revenue over time.

By Ron Tilles

Health Tech

Forus Secures $150M Series C, Reaches $3B Valuation

Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel.

By Marissa Plescia

Devices & Diagnostics, Startups, BioPharma

This Startup Wants to Make Glaucoma Surgery Recovery Easier

LEP Biomedical is developing a dissolvable implant that replaces weeks of self-administered eye drops after glaucoma surgery, aiming to fix the compliance problems that drive surgical failure rates as high as 40%.

By Katie Adams

MedCity Influencers

Is Radiology at a Structural Breaking Point? What Will Move It to a Better Future?

The path forward requires much more than whack-a-mole point solution replacement. It requires a more critical look at redesigning the entire workflow architecture

By Mike Moore

Payers, Policy

US Representative Scrutinizes Practices of IDR Entities

Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration practices and rising healthcare costs.

By Marissa Plescia

MedCity Influencers

Advancing Women’s Heart Health Through Prevention and Rapid Diagnosis

Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the difference between life and death for women.

By Lindy Carlstrom and Qian Ding

BioPharma, Pharma

GSK Pays $110M for Phase 1-Ready Hutchmed Asset in a New Class of Cancer Drugs

GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, and pancreatic cancers.

By Frank Vinluan

Health Tech

Oracle Health Execs Subpoenaed After VA Contract Costs Nearly Triple

The House VA Committee voted 19-0 to subpoena Oracle Health executives Larry Ellison and Mike Sicilia after learning the VA's EHR contract ballooned from $10 billion to $27 billion — despite Oracle's promise to Congress that it would absorb any costs beyond the original cap.

By Katie Adams